Federal Register #DEA-1703

DEA Notice: Application to Import Controlled Substances by LTS Therapy Systems, LLC

This notice from the Drug Enforcement Administration (DEA), part of the Department of Justice, concerns the application of LTS Therapy Systems, LLC to import controlled substances for research and development purposes. - Government Buyer: - Department of Justice (DOJ), Drug Enforcement Administration (DEA) - OEMs and Vendors: - LTS Therapy Systems, LLC (applicant and only vendor mentioned) - Products/Services Requested: - Importation of controlled substances as bulk active pharmaceutical ingredients (API) - Intended use: internal research, development, and analytical purposes only - No finished dosage forms for commercial sale are authorized - No specific product part numbers or quantities provided - Unique or Notable Requirements: - DEA is soliciting comments, objections, and hearing requests from interested parties, including registered bulk manufacturers - Importation is strictly limited to research and analytical use, not for commercial distribution - Place of Performance: - DEA facility in Springfield, Virginia - LTS Therapy Systems, LLC located in West Saint Paul, Minnesota

Description

LTS Therapy Systems, LLC has applied to be registered as an importer of basic classes of controlled substances. The application involves importing controlled substances as bulk active pharmaceutical ingredients (API) for internal research, development, and analytical purposes only. No other activities are authorized under this registration. Interested parties, including registered bulk manufacturers, may submit electronic comments or objections and request a hearing by May 18, 2026.

View original listing